Table 1 Associations of SUVmax and ADC with clinicopathologic prognostic factors in invasive ductal carcinoma
Factor | Number of cases (n = 118) | ADC mean (X 10–6 mm2/s) | P value | SUVmax | P value |
|---|---|---|---|---|---|
Tumor size (mm) | Â | Â | Â | Â | Â |
<20 | 49(41.88) | 942.3(412.3-1793.7) | 0.185 | 1.9(0–8.9) | <0001 |
20-50 | 57(48.72) | 969.3(599.8-1555.5) |  | 4.7(0–20.5) |  |
>50 | 11(9.40) | 1061.2(661.4-1402.9) | Â | 5.1(1.2-15.2) | Â |
LN metastasis | Â | Â | Â | Â | Â |
negative | 76(65.0) | 970.2(412.3-1793.7) | 0.655 | 2.5(0–18.7) | 0.003 |
positive | 41(35.0) | 962.1(599.8-1555.5) | Â | 4.8(1.2-20.5) | Â |
Histologic grade | Â | Â | Â | Â | Â |
1 | 39(33.3) | 962.9(412.3-1793.7) | 0.832 | 2.1(0–10.5) | <0001 |
2 | 58(49.57) | 966.7(565.2-1555.5) |  | 2.9(0–18.7) |  |
3 | 20(17.1) | 955.3(666.5-1402.9) | Â | 7.1(2.6-20.5) | Â |
ER | Â | Â | Â | Â | Â |
negative | 28(23.9) | 1043.6(764.1-1402.9) | 0.009 | 5.3(0–18.7) | 0.003 |
positive | 89(76.1) | 946.5(412.3-1793.7) |  | 2.8(0–20.5) |  |
PR | Â | Â | Â | Â | Â |
negative | 43(36.8) | 1012.99(753.5-1405.5) | 0.055 | 4.6(0–20.5) | 0.035 |
positive | 74(63.3) | 947.6(412.3-1793.7) |  | 2.8(0–14.1) |  |
HER 2 | Â | Â | Â | Â | Â |
negative | 67(57.26) | 922.3(412.3-1793.7) | 0.016 | 2.9(0–16.1) | 0.529 |
positive | 50(42.74) | 1019.8(599.8-1555.5) |  | 3.7(0–20.5) |  |
EGFR | Â | Â | Â | Â | Â |
negative | 92(80.0) | 962.3(412.3-1793.7) | 0.321 | 2.7(0–20.5) | 0.001 |
positive | 23(20.0) | 1041.0(666.5-1402.9) | Â | 5.3(1.3-18.7) | Â |
Ki-67 | Â | Â | Â | Â | Â |
<15 | 50(42.7) | 962.7(412.3-1793.7) | 0.998 | 2.3(0–8.6) | 0.001 |
≥15 | 67(57.3) | 969.3(568.4-1402.9) |  | 4.8(0–20.5) |  |
Age | Â | Â | Â | Â | Â |
<50 | 59(50.4) | 971.1(412.3-1555.5) | 0.577 | 3.2(0–16.1) | 0.301 |
≥50 | 58(49.6) | 959.6(565.2-1793.7) |  | 3.0(0–20.5) |  |